World Trade Organization
63 articles related to "World Trade Organization"
-
Trade and Public Health: a Decade of Double Standards
At the heart of almost every dispute about access to medicines lies this question: how do countries balance the need to protect public health against patent rights that lead to high medicine prices...
Op-eds & Articles – Last updated 22 November 2011
www.msfaccess.org/content/trade-and-public-health-decade-double-standards -
About the Novartis Drop the Case Campaign
In 2006 the drug company Novartis took the Indian government to court over its patent law, in a move that threatened access to affordable medicines produced in India for millions of people across the...
Static page – Last updated 28 March 2012
www.msfaccess.org/content/about-novartis-drop-case-campaign -
TRIPS, TRIPS Plus and Doha
The Agreement on Trade-Related Aspects of Intellectual Property Rights (or TRIPS Agreement) set the standards for intellectual property protection in the world today. It came into force on 1 January...
Static page – Last updated 22 July 2011
www.msfaccess.org/content/trips-trips-plus-and-doha -
What is a patent?
Below are four key concepts to help understand drug patents. 1. The rationale for patents Patents came about as a way to stimulate innovation. In order to encourage inventors to disclose their invention...
Static page – Last updated 21 July 2011
www.msfaccess.org/content/what-patent -
Seven Years On, ‘August 30 Decision’ Has Failed to Improve Access to Medicines and Remains Virtually Unused WTO Must Reform the Rules
Geneva, 27 October 2010 – As the World Trade Organization’s TRIPS Council meets in Geneva today to discuss how to improve a system intended to help countries without medicines manufacturing...
Press Release – Last updated 13 July 2011
www.msfaccess.org/about-us/media-room/press-releases/seven-years-%E2%80%98august-30-decision%E2%80%99-has-failed-improve-access -
MSF Workshop at the WTO on August 30th
Five years ago, the World Trade Organization came to an agreement, the so-called August 30th Decision, that was intended to increase access to affordable treatment for people in developing countries...
Events & Presentations – Last updated 25 September 2008
www.msfaccess.org/content/msf-workshop-wto-august-30th -
Globalization and medications : a new constraint for developing countries
This paper discusses the implications of the Marrakech agreements, the final GATT agreement instituting the World Trade Organization, including patent barriers to access to medicines. On April...
Report – Last updated 01 April 1999
www.msfaccess.org/content/globalization-and-medications-new-constraint-developing-countries -
Open letter to the WTO Member Countries on TRIPS and Access to Health Care Technology
Letter by MSF, HAI and CPT on the eve of the WTO Ministerial Conference in Seattle regarding intellectual property barriers to access to medicines and alternatives to TRIPS. Open letter to...
Statements, Speeches, Letters – Last updated 16 November 1999
www.msfaccess.org/content/open-letter-wto-member-countries-trips-and-access-health-care-technology -
NGO Statement to the WTO / WHO on Differential Pricing & Financing of Essential Drugs
Statement by Consumer Project on Technology, Health Action International, MSF, Oxfam and Treatment Action Group following the WHO/WTO workshop in Høsbjør, Norway. NGOs expressed disappointment...
Statements, Speeches, Letters – Last updated 08 April 2001
www.msfaccess.org/content/ngo-statement-wto-who-differential-pricing-financing-essential-drugs -
A Matter of Life and Death: The Role of Patents in Access to Essential Medicines
MSF briefing for the 4th WTO Ministerial Conference in Doha, Qatar. Includes articles on how generic competition brings down drug prices, TRIPS safeguards in use in developed countries, and why donations...
Statements, Speeches, Letters – Last updated 13 November 2001
www.msfaccess.org/content/matter-life-and-death-role-patents-access-essential-medicines
